Nuance Biotech, a China-based specialty pharmaceutical company, today announced series B fundraising of US$20 million with additional capital US$15 million tied to its acquisition of new products, led by C-Bridge Capital, a private equity firm focused on Chinese healthcare market. Shanghai-based Nuance Biotech was co-founded by Shao Yibo, a managing partner at Matrix Partners China and also co-founder of parenting community Babytree, and Mark Lotter, an industry veteran who built the commercial operations for multinational pharmaceutical firm AstraZeneca in China, … C-Bridge Capital Leads Series B Round In Chinese Pharmaceutical Firm Nuance Biotech appeared first on China Money Network.